FOLH1 and metastatic malignant neoplasm in the lymph nodes: Exemplarily for [177Lu]Lu-PSMA-617, Violet et al. 52 reported mean absorbed doses of 5.28 Gy/GBq (range: 0.41-10.71Gy/GBq) for bone metastases and of 3.91 Gy/GBq (range: 0.52-16.23 Gy/GBq) for lymph node metastases whereas Okamoto et al. 53 reported a mean absorbed dose for all metastases of 3.2 ± 2.6 Gy/GBq (range: 0.22 - 12.03 Gy/GBq) for [177Lu]Lu-PSMA I&T.